CAMBRIDGE, Mass. (AP) _ Bluebird Bio Inc. (BLUE) on Wednesday reported a loss of $71.4 million in its fourth quarter.
On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of $1.88.
The results missed Wall Street expectations. The average estimate of 10 analysts surveyed by Zacks Investment Research was for a loss of $1.85 per share.
The biotechnology company posted revenue of $1.6 million in the period, which matched Street forecasts.
For the year, the company reported that its loss widened to $263.5 million, or $7.07 per share. Revenue was reported as $6.2 million.
Bluebird shares have increased 20 percent since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $74, a climb of 39 percent in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on BLUE at https://www.zacks.com/ap/BLUE
Keywords: Bluebird Bio, Earnings Report